Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06375902
Other study ID # 2022289RNA
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date April 2024
Est. completion date October 2025

Study information

Verified date April 2024
Source IRCCS San Raffaele
Contact Mart Bosia, MD, PhD
Phone 00390226433299
Email bosia.marta@hsr.it
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Tracking down the difficulties in metaphor comprehension experienced by individuals with schizophrenia across different metaphor types and exploring the neurological correlates via EEG recording technique


Description:

The investigators will address the following objectives: - Primary Objective: Tracking down the difficulties in metaphor comprehension experienced by individuals with schizophrenia across different metaphor types and exploring the neurological correlates via EEG recording technique - Secondary Objectives: 1) Evaluate the interactions between performances in metaphor comprehension and individual differences in psychopathology, cognition, ToM and functioning; 2) Test if the altered neurophysiological patterns associated to the fragility of metaphor comprehension in schizophrenia can be restored through a rehabilitative training The investigators will enroll 32 schizophrenic patients and 32 healthy subjects as control sample. Participants will undergo an initial visit with a specialist psychiatrist who will verify that their conditions meet the criteria required by the study. Then, subjects will be tested for metaphor comprehension, as well as for the other variables included in the study, and the electrical brain activity will be registered through a 128 channel EEG. In the check-up visits (i.e., after the training) the following data will be collected: - Scores relating to cognitive, pragmatic (understanding of metaphors), theory of mind and global functioning performance scores - EEG recordings related to the process of understanding metaphors - Scores on scales that evaluate psychopathological severity


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 64
Est. completion date October 2025
Est. primary completion date October 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: For patients: - Age between 18 and 65 years - Diagnosis of Schizophrenia according to DSM V criteria - Ability to provide informed consent For healthy controls: - Age between 18 and 65 years - Ability to provide informed consent - Absence of psychiatric pathologies - Ability to speak Italian Exclusion Criteria: For patients: - Intellectual disability - Neurological disorder For healthy controls: - Presence of psychiatric pathologies - Difficulties in speaking Italian

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
PragmaCom
Cognitive behavioral intervention targeting the ability to understand metaphors

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
IRCCS San Raffaele

References & Publications (12)

Adamczyk P, Jani M, Ligeza TS, Plonka O, Bladzinski P, Wyczesany M. On the Role of Bilateral Brain Hypofunction and Abnormal Lateralization of Cortical Information Flow as Neural Underpinnings of Conventional Metaphor Processing Impairment in Schizophrenia: An fMRI and EEG Study. Brain Topogr. 2021 Jul;34(4):537-554. doi: 10.1007/s10548-021-00849-x. Epub 2021 May 10. — View Citation

Bambini V, Agostoni G, Buonocore M, Tonini E, Bechi M, Ferri I, Sapienza J, Martini F, Cuoco F, Cocchi F, Bischetti L, Cavallaro R, Bosia M. It is time to address language disorders in schizophrenia: A RCT on the efficacy of a novel training targeting the pragmatics of communication (PragmaCom). J Commun Disord. 2022 May-Jun;97:106196. doi: 10.1016/j.jcomdis.2022.106196. Epub 2022 Feb 2. — View Citation

Bambini V, Arcara G, Bosinelli F, Buonocore M, Bechi M, Cavallaro R, Bosia M. A leopard cannot change its spots: A novel pragmatic account of concretism in schizophrenia. Neuropsychologia. 2020 Mar 2;139:107332. doi: 10.1016/j.neuropsychologia.2020.107332. Epub 2020 Jan 7. — View Citation

Bambini V, Bertini C, Schaeken W, Stella A, Di Russo F. Disentangling Metaphor from Context: An ERP Study. Front Psychol. 2016 May 3;7:559. doi: 10.3389/fpsyg.2016.00559. eCollection 2016. — View Citation

Bambini V, Tonini E, Ceccato I, Lecce S, Marocchini E, Cavallini E. How to improve social communication in aging: Pragmatic and cognitive interventions. Brain Lang. 2020 Dec;211:104864. doi: 10.1016/j.bandl.2020.104864. Epub 2020 Nov 1. — View Citation

De Grauwe S, Swain A, Holcomb PJ, Ditman T, Kuperberg GR. Electrophysiological insights into the processing of nominal metaphors. Neuropsychologia. 2010 Jun;48(7):1965-84. doi: 10.1016/j.neuropsychologia.2010.03.017. Epub 2010 Mar 20. — View Citation

Harvey PD, Bowie CR, Friedman JI. Cognition in schizophrenia. Curr Psychiatry Rep. 2001 Oct;3(5):423-8. doi: 10.1007/s11920-996-0038-7. — View Citation

Iakimova G, Passerieux C, Laurent JP, Hardy-Bayle MC. ERPs of metaphoric, literal, and incongruous semantic processing in schizophrenia. Psychophysiology. 2005 Jul;42(4):380-90. doi: 10.1111/j.1469-8986.2005.00303.x. — View Citation

Mossaheb N, Aschauer HN, Stoettner S, Schmoeger M, Pils N, Raab M, Willinger U. Comprehension of metaphors in patients with schizophrenia-spectrum disorders. Compr Psychiatry. 2014 May;55(4):928-37. doi: 10.1016/j.comppsych.2013.12.021. Epub 2014 Jan 14. — View Citation

Rapp AM, Felsenheimer AK, Langohr K, Klupp M. The Comprehension of Familiar and Novel Metaphoric Meanings in Schizophrenia: A Pilot Study. Front Psychol. 2018 Jan 5;8:2251. doi: 10.3389/fpsyg.2017.02251. eCollection 2017. — View Citation

Rossetti I, Brambilla P, Papagno C. Metaphor Comprehension in Schizophrenic Patients. Front Psychol. 2018 May 9;9:670. doi: 10.3389/fpsyg.2018.00670. eCollection 2018. — View Citation

Thoma P, Daum I. Neurocognitive mechanisms of figurative language processing--evidence from clinical dysfunctions. Neurosci Biobehav Rev. 2006;30(8):1182-205. doi: 10.1016/j.neubiorev.2006.09.001. Epub 2006 Oct 31. — View Citation

* Note: There are 12 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Tracking down the difficulties in metaphor comprehension via a behavioural task Tracking down the difficulties in metaphor comprehension experienced by individuals with schizophrenia compared to healthy controls across different metaphor types through the Physical and mental metaphor task (PMM) (range values 0-28, higher scores mean a better outcome). through study completion, an average of 2 years
Primary Tracking down the difficulties in metaphor comprehension via task during electrophysiological recording Exploring the difference in the neurological correlates (via electrophysiological recording technique) between patients and controls. Electrophysiological indexes that will be evaluated are event-related potential after the stimulus presentation. through study completion, an average of 2 years
Secondary Evaluation of psychopathology Evaluate psychopathology with the Positive and Negative Syndrome scale (PANSS) (range values 30-210, higher scores mean a worse outcome). through study completion, an average of 2 years
Secondary Evaluation of cognition Evaluate cognition in schizophrenia with the Brief assessement of cognition in schizophrenia (BACS) (range total score 0-1, higher scores mean a better outcome). through study completion, an average of 2 years
Secondary Evaluation of Theory of Mind Evaluate Theory of Mind with the Picture sequencing task (PST) (range score 0-56, higher scores mean a better outcome). through study completion, an average of 2 years
Secondary Evaluation of functioning Evaluate functioning, with the Quality of life scale (QLS) (range score 0-126, higher scores mean a better outcome). through study completion, an average of 2 years
Secondary Evaluate the efficacy of a rehabilitative training in restoring metaphor comprehension ability Test te improvement of metaphor comprehension, evaluated with the Physical and mental metaphor task (PMM) (range values 0-28, higher scores mean a better outcome). through study completion, an average of 2 years
See also
  Status Clinical Trial Phase
Completed NCT04559529 - Pharmacological Modulation of Hippocampal Activity in Psychosis 2 Phase 2
Recruiting NCT06134661 - Accelerated rTMS for Psychomotor Slowing N/A
Completed NCT05759091 - Effect of Applying Cognitive Defusion Techniques on Mindful Awareness, Cognitive Fusion and Believability of Delusions Among Clients With Schizophrenia N/A
Not yet recruiting NCT05995457 - The IM-ZBULLE Study : " Z-track " and " Airlock " Techniques During Intramuscular Injection of Haloperidol Decanoate N/A
Completed NCT04777266 - Music Therapy for People With Schizophrenia and Relates Psychosis. N/A
Not yet recruiting NCT06341517 - Brain Circuitry Therapeutics for Schizophrenia N/A
Not yet recruiting NCT05550155 - Efficacy of Maintenance Repetitive Transcranial Magnetic Stimulation (rTMS) in Auditory Verbal Hallucinations N/A
Terminated NCT04277936 - Pharmacologic Modulation of Hippocampal Activity in Psychosis Phase 2
Active, not recruiting NCT04748679 - Cognitive Behavioral Therapy (CBT) Study Evaluating the Updating of Persecutory Beliefs N/A
Recruiting NCT05858255 - Hjernegym - Effects of Exergaming in Psychosis: a Clinical Intervention Study N/A
Not yet recruiting NCT05763966 - Uppsala Psychosis Cohort
Not yet recruiting NCT05731414 - Outcomes From Remediation and Behavioural Intervention Techniques N/A
Completed NCT04898270 - Adjunctive Use of Fute (Flupentixol) in Multi-acting Receptor-targeted Antipsychotics Treated Schizophrenia Patients Phase 4
Completed NCT04659161 - A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-2) Phase 3
Completed NCT04260763 - Evaluating a Novel Mobile App for Social Cognition in Psychosis N/A
Recruiting NCT04853485 - Repetitive Transcranial Magnetic Stimulation in Early Psychosis and The Functional Connectivity Biotypes N/A
Completed NCT04738123 - A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-3) Phase 3
Recruiting NCT05445180 - Investigating the Neural Correlates of Cognitive Function in Psychosis Patients and Non-Psychiatric Controls With Cannabis Use N/A
Completed NCT04773171 - Efficacy of Computer-assisted Cognitive Remediation in Patients With Schizophrenia N/A